Multicentre Dose-Ranging Study on the Efficacy of USPIO Ferumoxtran-10 for Liver MR Imaging
- 1 September 2000
- journal article
- clinical trial
- Published by Elsevier in Clinical Radiology
- Vol. 55 (9) , 690-695
- https://doi.org/10.1053/crad.2000.0504
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.American Journal of Roentgenology, 1999
- Safety profile of ultrasmall superparamagnetic iron oxide ferumoxtran‐10: Phase II clinical trial dataJournal of Magnetic Resonance Imaging, 1999
- LIVER-SPECIFIC MR IMAGING CONTRAST AGENTSRadiologic Clinics of North America, 1998
- Contrast-enhanced MR imaging of the liver.Radiology, 1997
- Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions.Radiology, 1995
- Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227).American Journal of Roentgenology, 1995
- Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: Ferumoxides, ferumoxtran, ferumoxsilMagnetic Resonance Imaging, 1995
- Surface properties of superparamagnetic iron oxide MR contrast agents: Ferumoxides, ferumoxtran, ferumoxsilMagnetic Resonance Imaging, 1995
- Liver MR imaging with iron oxides: toward consensus and clinical practice.Radiology, 1994
- Phase I clinical evaluation of a new iron oxide MR contrast agentJournal of Magnetic Resonance Imaging, 1994